YahooOctober 19, 2026 at 10:07 AM NY8 Days Ago
Amgen Has the Drugs and the Dividend. Now It Needs the Growth
Amgen Inc. (NASDAQ:AMGN) has carved out a strong spot in the biotech world, thanks to its lineup of medicines for cancer, heart disease, inflammation, and some rare conditions. The company’s tried-and-true products bring in plenty of cash, and its newer treatments show real promise for growth. For those looking beyond a single pharmaceutical stock, the 10 […]
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
